BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRODUCTS ON MARKET: Highly purified enzymes and related biochemicals for clinical diagnostics,
immunodiagnostics, biosensors, diagnostic probe and research applications
(includes alkaline phosphatase, peroxidase, glucose oxidase, urease,
catalase, aldehyde dehydrogenase, hexokinase, phospho-enolpyruvate
carboxylase, glycerol-3-phosphate dehydrogenase, ascorbate oxidase,
cholesterol esterase, xanthine oxidase, alpha-glucosidase, elastase,
enterokinase, deoxyribonuclease and ribonuclease)
Boojum Research Ltd.
KEY PERSONNEL: Margarete Kalin; President
139 Amelia Street
Toronto M4X 1E6, Canada
Phone: (416) 861-1086; Fax: (416) 861-0634
Web: www.boojumresearch.com; E-mail: margarete.kalin@utoronto.ca
EMPLOYEES: 2 employees, 4 specialty contractors
HISTORY: Founded in 1987
FACILITIES: 850 sq. ft. headquarters
STOCK-FINANCIAL HISTORY: Privately held
BUSINESS STRATEGY: Seek marketing, investment and joint venture opportunities
RESEARCH & DEVELOPMENT: Wetland microbiology and ecosystem recovery
Bioremediation of mining sites
Environmental mining
PRODUCTS ON MARKET: Chara process
Microbiological AMD treatment
Biological polishing
Ecological engineering
ARUM (acid reduction using microbiology) process
Project management for clean-up of mine sites
Boston Life Sciences Inc.
85 Main Street
Hopkinton MA 01748, US
Phone: (508) 497-2360; Fax: (508) 497-9964
Web: www.bostonlifesciences.com
E-mail: ir@bostonlifesciences.com
KEY PERSONNEL: Peter G. Savas; Chairman and CEO
Mark J. Pykett, Ph.D.; President and COO
Kenneth L. Rice Jr.; Exec. VP, Finance and CFO
Mark R. Hurtt, M.D.; CMO
Irene Gonzalez, Ph.D.; Sr. VP, Protein Development
Noel J. Cusack, Ph.D.; Sr. VP, Preclinical Development
Richard Thorn, Ph.D.; Sr. VP, Program Operations
Sharon Correia; Director, Corporate Communications and Investor Relations
EMPLOYEES: 24 employees
HISTORY: Founded in 1992 by the Castle Group and Dr. Marc Lanser
Completed reverse merger with Greenwich Pharmaceuticals Inc. to become
a public company (6/95)
Member--Biotechnology Industry Organization
Member--Massachusetts Biotechnology Council
Copyright ©2006 AHC Media ® 93